NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...

Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...

Please provide your email address to receive an email when new articles are posted on . The Stentrode brain-computer interface offers a non-invasive, nonsurgical solution for paralysis. Additional ...

Can the human mind control external digital devices by thoughts alone? Scientists affiliated with the University of Melbourne and Synchron, Inc. published earlier this week in the Journal of ...

Synchron, a New York, NY-based manufacturer of non-surgical brain-computer interface technology, said it has raised a $200 million series D round. The funds are expected to accelerate ...

For the first time, an individual has been seen publicly controlling an iPad entirely through thought, thanks to Apple's new brain-computer interface (BCI) protocol and Synchron's implantable ...

The brain-computer interface developer Synchron has shown that its minimally invasive device can help connect a patient with an iPad, allowing them to control the device entirely by thought using ...

New York-based Synchron, a brain-computer interface (BCI) company, has raised $200 million in Series D funding, bringing its total raise to $345 million. Double Point Ventures led the round, with ...

These are exciting times at the intersection of artificial intelligence (AI) and neuroscience. The trend in brain-computer interfaces (BCIs) is toward flexible and less invasive devices that can ...

New York-based Synchron, a brain-computer interface (BCI) company, has released a video showing an ALS patient using an iPad controlled entirely by thought in what it says is the "first-ever public ...

Synchron has reeled in another $200 million in a series D round—cash the company said it will use to expand operations and accelerate commercialization of its nonsurgical brain-computer interface (BCI ...